Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Nanomedicine 2013

Andrei Gartel's Biography



Andrei Gartel, Associate Professor, University of Illinois at Chicago

Andrei L. Gartel, PhD is an Associate Professor in the Departments of Medicine and Biochemistry & Molecular Genetics at the University of Illinois at Chicago. He is the author of more than 70 peer-review publications that include more than 15 reviews with more 3000 citations. His scientific interests include the regulation of cell cycle progression, cyclin dependent kinase inhibitors, oncogenic transcription factors FOXM1 and c-Myc, and mechanisms of action of anticancer drugs. Recently his lab identified proteasome inhibitors as first chemical inhibitors of oncogenic transcription factor FOXM1, which is overexpressed in a majority of human cancers. He received his funding from NIH, DOD and private companies/foundations. He is an academic editor of PLOS ONE.

Andrei Gartel Image

CANCELLED - Micelle-encapsulated Thiostrepton is an Effective Nanomedicine for Inhibiting Tumor Growth

Friday, 12 April 2013 at 16:15

Add to Calendar ▼2013-04-12 16:15:002013-04-12 17:15:00Europe/LondonCANCELLED - Micelle-encapsulated Thiostrepton is an Effective Nanomedicine for Inhibiting Tumor GrowthNanomedicine 2013 in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

We explored the potential in vivo anticancer properties of thiostrepton, delivered through nanoparticle encapsulation to xenograft models of breast and liver cancer. Maximum accumulation of micelle-thiostrepton nanoparticles (100nm in diameter, -16mV in zetapotential) into tumors was retained for at least 24 hours and reduced tumor growth of human cancer xenografts.


Add to Calendar ▼2013-04-11 00:00:002013-04-12 00:00:00Europe/LondonNanomedicine 2013Nanomedicine 2013 in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com